NO893366L - Alfa-underenheten til lfa-1 leukocytadhesjons-reseptoren. - Google Patents

Alfa-underenheten til lfa-1 leukocytadhesjons-reseptoren.

Info

Publication number
NO893366L
NO893366L NO89893366A NO893366A NO893366L NO 893366 L NO893366 L NO 893366L NO 89893366 A NO89893366 A NO 89893366A NO 893366 A NO893366 A NO 893366A NO 893366 L NO893366 L NO 893366L
Authority
NO
Norway
Prior art keywords
lfa
alfa
sub
unit
molecules
Prior art date
Application number
NO89893366A
Other languages
English (en)
Norwegian (no)
Other versions
NO893366D0 (no
Inventor
Timothy Springer
Richard Larson
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of NO893366D0 publication Critical patent/NO893366D0/no
Publication of NO893366L publication Critical patent/NO893366L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
NO89893366A 1988-08-23 1989-08-22 Alfa-underenheten til lfa-1 leukocytadhesjons-reseptoren. NO893366L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23522788A 1988-08-23 1988-08-23
US32101789A 1989-03-09 1989-03-09

Publications (2)

Publication Number Publication Date
NO893366D0 NO893366D0 (no) 1989-08-22
NO893366L true NO893366L (no) 1990-02-26

Family

ID=26928699

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893366A NO893366L (no) 1988-08-23 1989-08-22 Alfa-underenheten til lfa-1 leukocytadhesjons-reseptoren.

Country Status (14)

Country Link
EP (1) EP0362526B1 (de)
JP (1) JPH02306999A (de)
KR (1) KR900002796A (de)
AT (1) ATE123810T1 (de)
AU (1) AU634974B2 (de)
DE (1) DE68923048T2 (de)
DK (1) DK412589A (de)
ES (1) ES2075016T3 (de)
FI (1) FI893916L (de)
GR (1) GR3017303T3 (de)
HU (1) HUT53673A (de)
IL (1) IL91369A (de)
NO (1) NO893366L (de)
PT (1) PT91503B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006592A1 (en) * 1987-02-26 1988-09-07 Dana-Farber Cancer Institute, Inc. Cloning of lfa-1
US5395929A (en) * 1987-12-15 1995-03-07 Dana Farber Cancer Institute Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
EP0362531B1 (de) 1988-09-01 1999-11-10 Bayer Corporation Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
JPH04505613A (ja) * 1989-03-09 1992-10-01 ダナ・ファーバー・キャンサー・インスティチュート 白血球付着レセプター
EP0462184A4 (en) * 1989-03-09 1992-01-08 Dana Farber Cancer Institute Method of treating viral infections using lfa-1
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
ATE184049T1 (de) * 1990-07-20 1999-09-15 Bayer Ag Multimere formen des menschlichen rhinovirus- rezeptorproteins
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5120830A (en) * 1990-10-25 1992-06-09 Washington University Inhibitory peptides against α-2, β-1 mediated mg++ dependent adhesion of platelets to collagen
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
EP0762886A4 (de) * 1994-04-19 1999-03-31 Univ Kansas Icam-1/lfa-1 kurzkettigen peptide und methoden zu deren verwendung
US6017734A (en) * 1995-07-07 2000-01-25 The Texas A & M University System Unique nucleotide and amino acid sequence and uses thereof
US6075004A (en) 1996-04-26 2000-06-13 The University Of Kansas Peptide compositions which induce immune tolerance and methods of use
AU4825699A (en) * 1998-06-19 2000-01-05 Genzyme Corporation Identification and use of differentially expressed genes and polynucleotide sequences
EP1169048A4 (de) * 1998-07-06 2002-07-17 Glenn D Prestwich Analoge der hyaluronsäure und entsprechende anwendungsverfahren
DK1512695T3 (da) * 2003-09-04 2009-03-16 Biomay Ag Hypoallergeniske polypeptider på fiske-parvalbumin
AU2004287875B2 (en) 2003-11-05 2011-06-02 Bausch + Lomb Ireland Limited Modulators of cellular adhesion
EP2168986A3 (de) 2004-02-19 2010-07-28 Genentech, Inc. Antikörper mit korrigiertem CDR
SI1881823T1 (sl) 2005-05-17 2015-04-30 Sarcode Bioscience Inc. Sestavki in postopki za zdravljenje bolezni oäśesa
CA2702984C (en) 2007-10-19 2017-04-11 Sarcode Corporation Compositions and methods for treatment of diabetic retinopathy
WO2009139817A2 (en) 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
US8378105B2 (en) 2009-10-21 2013-02-19 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
EP2877465A4 (de) 2012-07-25 2016-05-11 Sarcode Bioscience Inc Lfa-1-hemmer und polymorph davon

Also Published As

Publication number Publication date
PT91503B (pt) 1996-04-30
EP0362526A2 (de) 1990-04-11
IL91369A0 (en) 1990-04-29
AU634974B2 (en) 1993-03-11
EP0362526A3 (en) 1990-07-18
KR900002796A (ko) 1990-03-23
AU4014589A (en) 1990-03-01
HUT53673A (en) 1990-11-28
DK412589D0 (da) 1989-08-22
ATE123810T1 (de) 1995-06-15
JPH02306999A (ja) 1990-12-20
FI893916A7 (fi) 1990-02-24
NO893366D0 (no) 1989-08-22
PT91503A (pt) 1990-03-08
GR3017303T3 (en) 1995-12-31
ES2075016T3 (es) 1995-10-01
FI893916L (fi) 1990-02-24
EP0362526B1 (de) 1995-06-14
FI893916A0 (fi) 1989-08-21
DE68923048D1 (de) 1995-07-20
IL91369A (en) 1994-08-26
DE68923048T2 (de) 1995-11-16
DK412589A (da) 1990-02-24

Similar Documents

Publication Publication Date Title
NO893367L (no) Alfa-underenheten av mac-1 leukocytadhesjons-reseptoren.
NO893366D0 (no) Alfa-underenheten til lfa-1 leukocytadhesjons-reseptoren.
DE59309564D1 (de) Kleb- und dichtstoff
MX9203033A (es) Moleculas de adherencia intercelular y sus ligados de fijacion.
ES2124373T3 (es) Procedimiento para la preparacion de derivados del acido n-acil-n,n',n'-etilendiamintriacetico.
BR0314825A (pt) Superfìcies resistentes à adessão celular
AU4088685A (en) Novel monoclonal antibodies to human renin and hybridoma cells, processes for their preparation and their applications
ES2081857T3 (es) Nuevos inhibidores de alpha-glucosidasa.
MX9203469A (es) Molecula de adherencia intercelular-2 y sus ligandos de fijacion.
DE3772748D1 (de) Selbstausrichtung von raumfahrzeugsbeschleunigungsmessern.
FI864898A0 (fi) Menetelmä glukoosisiirappien ja puhdistettujen tärkkelysten tuottamiseksi vehnän ja muiden viljakasvien pentosaaneja sisältävistä tärkkelyksistä
GR890100033A (el) Μέ?οδος παρασκευής διδεοξυδιδευδροκαρβοκυκλικών νουκλεοσιδών.
MX9203212A (es) Moleculas de adherencia intercelular y sus ligandos de fijacion.
ATE158082T1 (de) Bestimmung von peptidmotiven auf mhc-molekülen
DE3867456D1 (de) Aldehyd-staerke saettigende klebstoffe zum zusammenfuegen von laminaten.
DE3773081D1 (de) Positionierung von glasplatten vor dem biegen.
NL8602076A (nl) Basische en kationogene, sulfonzuurgroepen bevattende, monoazonen bisazoverbindingen en werkwijzen voor het toepassen van deze verbindingen.
DE68917577D1 (de) Stärke-Klebstoff von hoher Konzentration.
NO162288C (no) Fremgangsmaate til fremstilling av etenpolymerer og katalytisk system som er aktivt for polymerisasjon av eten.
DE58903477D1 (de) Fluessige, strahlenhaertbare ueberzugsmasse fuer die beschichtung von glasoberflaechen.
DK597886D0 (da) Fremgangsmaade til paafaering af tryk paa laedersubstrater
FR2391235A1 (fr) Utilisation d'amidines, comme accelerateurs de reaction, lors de la preparation de polyurees
DK163566C (da) Anvendelse af hygromycin og epihygromycin til fremstilling af et medikament til behandling af svinedysenteri
DE3462257D1 (en) 4-amino-3-imidozolin-2-on and (2-methoxy-2-imino-ethyl) urea, their preparation and application
ATE137241T1 (de) Oligosaccharides